Inflection Biosciences Announces Appointment of Murray Yule, M.D., Ph.D., as Chief Medical Officer
(06 Feb 2020) Dublin, Ireland, February 6th, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the...
top of page
News
Press Releases
- Jan 31, 2020
Inflection Biosciences to present at BIO CEO & Investor Conference 2020.
Dublin, Ireland, January 31, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
- Nov 26, 2019
Inflection Biosciences Selected as Tech Tour Contest Finalist for 2019
Dublin, Ireland, November 26, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
- Oct 30, 2019
Inflection Biosciences Announces Passing of Co-Founder and Board Member John Scanlan
Dublin, Ireland, October 30, 2019 – Inflection Biosciences Ltd today announced that John Scanlan, a co-founder and a member of its Board...
- Sep 9, 2019
Inflection Biosciences Announces Pre-clinical Data to be Presented at IASLC 2019 World Conference.
Dublin, Ireland, September 9th, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
- Aug 7, 2019
Inflection Biosciences Announces Publication of Positive Data for PIM/PI3K/mTOR Inhibitor
Dublin, Ireland, August 7, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
- Jul 18, 2019
Inflection Biosciences and AUM Biosciences announce Global License Agreement for PIM/PI3K/mTOR
Dublin, Ireland, 18 July 2019 – Inflection Biosciences (Inflection), a company developing innovative therapeutics for the treatment of...
- Nov 28, 2018
Inflection Biosciences Announces Pre-clinical Data to be Presented at 2018 AACR Targeting PI3K/mTOR
Dublin, Ireland, November 28th, 2018 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
- Nov 22, 2018
Inflection Biosciences Announces Pre-clinical Data on IBL-202 to be Presented at ASH 2018 Meeting
Dublin, Ireland, November 22nd, 2018 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
- Nov 1, 2018
Inflection Biosciences Announces Research Collaboration with MD Anderson Cancer Center.
Dublin, Ireland, November 1, 2018 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
bottom of page